Literature DB >> 3057641

Intravesical interferon alfa in the treatment of superficial bladder cancer.

R D Williams1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3057641

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


× No keyword cloud information.
  3 in total

1.  Recombinant bacille Calmette-Guérin (BCG) expressing human interferon-alpha 2B demonstrates enhanced immunogenicity.

Authors:  Y Luo; X Chen; R Han; M A O'Donnell
Journal:  Clin Exp Immunol       Date:  2001-02       Impact factor: 4.330

Review 2.  Recombinant BCG to Enhance Its Immunomodulatory Activities.

Authors:  Magdalena Kowalewicz-Kulbat; Camille Locht
Journal:  Vaccines (Basel)       Date:  2022-05-23

Review 3.  Interferon-alpha in malignant and viral diseases. A review.

Authors:  R T Dorr
Journal:  Drugs       Date:  1993-02       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.